Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI

J Am Coll Cardiol. 2021 May 11;77(18):2348-2350. doi: 10.1016/j.jacc.2021.03.015.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Humans
  • Middle Aged
  • Prospective Studies
  • Proto-Oncogene Proteins c-met / blood*
  • ST Elevation Myocardial Infarction / blood*

Substances

  • Biomarkers
  • MET protein, human
  • Proto-Oncogene Proteins c-met